The Deloitte Recap16th Annual Allicense Meeting

Palace Hotel, San Fransisco, CA
May 01, 2012 - May 02, 2012

Jon Norris to lead keynote panel on Venture Capital at Allicense Conference

Venture Capital: Stepping Up or Stepping Out?
Overall equity financing for biopharma was up in 2011, but venture investing was down. This group of leading venture capitalists will discuss the state of private venture investing in biopharma and debate what can be expected in the next year.

  • Session Chair: Jonathan Norris, Managing Director, Silicon Valley Bank
  • Chris Ehrlich, General Partner, InterWest Partners
  • Michael Grey, Venture Partner, Pappas Ventures
  • Patrick Heron, General Partner, Frazier Healthcare,Biopharma Venture Team

Learn More and Register